Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

34.64
Delayed Data
As of Aug 28
 +0.36 / +1.05%
Today’s Change
19.31
Today|||52-Week Range
36.20
+27.21%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close34.28
Today’s open34.19
Day’s range34.02 - 34.76
Volume199,288
Average volume (3 months)272,086
Market cap$1.3B
Dividend yield--
Data as of 4:04pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+40.15%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio36.1
Price/Sales3.68
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+1.21+2.60%
ZSPHZS Pharma Inc+0.78+1.51%
EGRXEagle Pharmaceutical...+2.68+3.31%
PTCTPTC Therapeutics Inc-0.49-1.19%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.50
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers